Testosterone replacement therapy is associated with an increased risk of urolithiasis-Reference-Cited by-同舟云学术

Testosterone replacement therapy is associated with an increased risk of urolithiasis

Published:2019-03-23 Issue:12 Volume:37 Page:2737-2746
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

McClintock Tyler R.,Valovska Marie-Therese I.,Kwon Nicollette K.,Cole Alexander P.,Jiang Wei,Kathrins Martin N.,Bhojani Naeem,Haleblian George E.,Koehlmoos Tracey,Haider Adil H.,Basaria Shehzad,Trinh Quoc-Dien^ORCID

Funder

U.S. Department of Defense

Orthopaedic Research Foundation

National Institutes of Health

Brigham Research Institute

Bruce A. Beal and Robert L. Beal Surgical Fellowship

Conquer Cancer Foundation

Defense Health Agency

Prostate Cancer Foundation

Vattikuti Urology Institute

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02726-6.pdf

Reference30 articles.

1. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018) Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103(5):1715–1744. https://doi.org/10.1210/jc.2018-00229

2. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, O’Neill TW, Bartfai G, Casanueva FF, Forti G, Giwercman A, Han TS, Kula K, Lean ME, Pendleton N, Punab M, Boonen S, Vanderschueren D, Labrie F, Huhtaniemi IT (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363(2):123–135. https://doi.org/10.1056/NEJMoa0911101

3. Handelsman DJ (2015) Irrational exuberance in testosterone prescribing: When will the bubble burst? Med Care 53(9):743–745. https://doi.org/10.1097/MLR.0000000000000416

4. Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER 3rd, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS, Testosterone Trials I (2016) Effects of testosterone treatment in older men. N Engl J Med 374(7):611–624. https://doi.org/10.1056/NEJMoa1506119

5. Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM, Eder R, Tennstedt S, Ulloor J, Zhang A, Choong K, Lakshman KM, Mazer NA, Miciek R, Krasnoff J, Elmi A, Knapp PE, Brooks B, Appleman E, Aggarwal S, Bhasin G, Hede-Brierley L, Bhatia A, Collins L, LeBrasseur N, Fiore LD, Bhasin S (2010) Adverse events associated with testosterone administration. N Engl J Med 363(2):109–122. https://doi.org/10.1056/NEJMoa1000485

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low serum testosterone is associated with an increased risk of first-time renal calculi in men without testosterone replacement therapy;International Journal of Impotence Research;2024-08-20

2. The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS);Diagnostics;2023-08-30

3. Prevalence of secondary erythrocytosis in men receiving testosterone therapy;Canadian Urological Association Journal;2023-04-11

4. Hypogonadism and urologic surgeries: a narrative review;Translational Andrology and Urology;2022-07

5. Sex Differences and the Risk of Kidney Stones;Seminars in Nephrology;2022-03